Agenda

Session 3: Future Field Diagnostics

Time	Session	Presenter	Goals
2.00- 3.00 80mins	Session 3: Current pipeline and future tests	Eric Goemaere, MSF Ruth McNerney LSHTM
2.00-2.10 10mins	Field tests: What, where & why?	Gilles van Cutsem MSF S Africa	What do we mean by a field appropriate test?
2.10-2.25 15mins	Current pipeline for commercial diagnostic tests	Mark Perkins FIND	Available now vs. next year vs ‘promising techniques’
2.25-2.40 15mins	Current pipeline for non-commercial diagnostic techniques	Andrew Ramsay TDR/WHO	Models of provision: commercial kits vs techniques
2.40-3.10 30mins	Discussion: will the current pipeline produce what patients need?	Panel including all of the above + Anandi Martin, IMT Antwerp + Pamela Hepple, Manson Unit MSF	Are we satisfied? Are the field needs being addressed? Will they be met with current product pipeline? Commercial vs non-proprietary techniques Centralised vs point of care Control and quality control Try to bring out gaps, again, highlight lack of likely tools, failure of commercial model, etc
3.10-3.40 30mins	Coffee and posters